Modelos de datos seleccionados

Debe iniciar sesión para seleccionar modelos de datos para descargar o realizar un análisis.

3 Resultados de la búsqueda.
Relevancia Evaluación Nuevo primero Antiguo primero

HIS talk after biopsy breast cancer - HIS

- 20/9/21 - 1 formulario, 4 itemgroups, 44 items, 2 idiomas
Itemgroups: Patientenaufkleber groß, Patienteninformation, geplante Operation, Patienteninformation II
documentation standard - breast cancer - gynecology, with friendly permission (Dr. Tio) - kooperatives Brustzentrum Münster, Bereich Senologie an der Klinik und Poliklinik für Frauenheilkunde und Geburtshilfe - Leitung: Dr. med. Joke Tio

HIS cancer conference after biopsy breast cancer - HIS

- 15/5/13 - 1 formulario, 10 itemgroups, 69 items, 2 idiomas
Itemgroups: Patientenaufkleber groß, Tumorkonferenz, Angaben zum Patienten, Verlauf, Pathologie Befund, Fragestellung, Subformular, MDT (MIB), Aktion, Empfehlungen der Tumorkonferenz
HIS cancer conference after biopsy breast cancer

Effects of Low-fat and high-fat meals on the Pharmacokinetics of Lapatinib in ErB2+ Breast Cancer patients, NCT00821054 - Liver biopsy

- 9/1/21 - 1 formulario, 15 itemgroups, 158 items, 1 idioma
Itemgroups: Administrative Data, Date of liver biopsy, Liver Biopsy size, Liver Biopsy Final Diagnosis, Liver Architecture, Description of Liver Cells or Hepatocytes, Liver Cell or Hepatocyte Inclusions or Vacuoles, Hepatocyte or Liver Cell Nuclear Abnormalities, Liver or Lobular Infiltrates, Portal Tract Inflammation, Bile Ducts, Portal Veins, Liver Infections, Liver: Parasites or Ova, Histologic Staining or Additional Studies Obtained
Study ID: 111582 Clinical Study ID: 111582 Study Title: An Open Label Study to Examine the Effects of Low-fat and High-fat Meals on the Pharmacokinetics of Orally Administered Lapatinib in Metastatic ErbB2 Positive Breast Cancer Patients. Patient Level Data: Study Listed on ClinicalStudyDataRequest.com Clinicaltrials.gov Identifier: NCT00821054 https://clinicaltrials.gov/ct2/show/NCT00821054 Sponsor: GlaxoSmithKline Collaborators: N/A Phase: Phase 1 Study Recruitment Status: Completed Generic Name: Lapatinib Trade Name: N/A Study Indication: Neoplasms, Breast The study consists of a screening, four study visits at day-1, week 1, 2 and 3 and a follow-up visit. This document is supposed to document the results of a possible liver biopsy.

Ayuda

Do you need help on how to use the search function? Please watch the corresponding tutorial video for more details and learn how to use the search function most efficiently.

Watch Tutorial